Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06072131
Title To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL (CRESCENDO)
Acronym CRESCENDO
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Acrotech Biopharma Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Rutgers Cancer Institute of New Jersey RECRUITING New Brunswick New Jersey 08901 United States Details
Valley Cancer Associates RECRUITING Harlingen Texas 78550 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field